PhD fellowship: biochemical and molecular function of ubiquitin-directed protease DDI2, in the Svejstrup laboratory, Department of Cellular and Molecular Medicine (ICMM)We are offering a PhD fellowship for a talented and highly motivated student interested in investigating the biochemical and molecular function of ubiquitin-directed protease DDI2. The successful candidate will be employed in the Svejstrup laboratory at the Institute of Cellular and Molecular Medicine (ICMM) at the Faculty of Health and Medical Sciences, University of Copenhagen. In September 2020, the Svejstrup Laboratory re-located from the Francis Crick institute in London to the ICMM (https://icmm.ku.dk/english/research-groups/svejstrup-group/research-group/). Research techniques used in the laboratory include molecular cell biology, biochemistry (including protein purification, proteomics, and reconstitution of key processes with purified factors in vitro) and modern genome-wide techniques (ChIP-Seq, RNA-Seq, TT-Seq, etc), as well as genomic screening (siRNA and CRISPR screens). Svejstrup lab represents cutting-edge interdisciplinary research and training and is located at the Panum Institute (18.6) within the ICMM. We have access to state-of-the-art facilities for mass spectrometry, flow cytometry, cell engineering, and next-generation sequencing. The project will be an investigation of the biochemical and cellular function of the DDI2 protease, required for maintaining proteostasis during cellular stress (Dirac-Svejstrup et al., Molecular Cell 2020). DDI2 protease targets the transcription factor NRF1. NRF1 is normally associated with the ER. However, during proteasomal stress, proteolysis by DDI2 releases NRF1, and this cleaved form enters the nucleus and up-regulates proteasome genes. In this way, proteasome inhibition feeds back to transcription and results in up-regulation of the proteasome, via DDI2 protease activity. Proteasome inhibitors are now widely used in cancer therapy, so this has obvious clinical implications. Indeed, if upregulation of proteasome expression could be prevented through combination therapy with DDI2 inhibitors, the potency of the proteasome inhibitors that have transformed the treatment of blood cancers should be dramatically increased. Principal supervisor is Professor Jesper Svejstrup, ICMM, e-mail: jsvejstrup@sund.ku.dk. Start: December 2022 or soon thereafter. Your key tasks as a PhD student at SUND are:
Key criteria for the assessment of applicants Applicants must have qualifications corresponding to a master’s degree Biochemistry, Biology, Biomedicine or similar (equivalent of the Danish candidate, 3 + 2 years) related to the subject area of the project. Other important criteria are:
Place of employment The place of employment is at the Department of Cellular and Molecular Medicine (ICMM), University of Copenhagen. Our lab at the ICMM offers a creative and ambitious scientific environment, with nine different nationalities presently represented and English as the working language. We strive to produce research results with high international impact, focusing on the functional cell, its genetic components, and molecular cellular mechanisms in a medical context. The employment as PhD fellow is full time (37 working hours per week in average) and for three years. Questions For specific information about the PhD fellowship, please contact the principal supervisor. General information about PhD study at the Faculty of Health and Medical Sciences is available at the Graduate School’s website: https://healthsciences.ku.dk/phd/guidelines/. Application procedure Your application must be submitted electronically by clicking ‘Apply now’ below. The application must include the following documents in PDF format:
Application deadline: Sunday 18 September 2022, 23.59 p.m. CET. The further process After the expiry of the deadline for applications, the authorized recruitment manager selects applicants for formal assessment on the advice of the hiring committee. All applicants are then immediately notified whether their application has been passed for assessment by an unbiased assessor. The assessor makes a non-prioritized assessment of the academic qualifications and experience with respect to the above-mentioned area of research, techniques, skills, and other requirements listed in the advertisement. Once the assessment work has been completed each applicant has the opportunity to comment on the part of the assessment that relates to the applicant him/herself. The University of Copenhagen wishes to reflect the surrounding community and invites all regardless of personal background to apply for the position. Part of the International Alliance of Research Universities (IARU), and among Europe’s top-ranking universities, the University of Copenhagen promotes research and teaching of the highest international standard. Rich in tradition and modern in outlook, the University gives students and staff the opportunity to cultivate their talent in an ambitious and informal environment. An effective organisation – with good working conditions and a collaborative work culture – creates the ideal framework for a successful academic career. ContactJesper Qualmann Svejstrup
E-mail: jsvejstrup@sund.ku.dk
InfoApplication deadline: 18-09-2022
Employment start: 01-12-2022
Working hours: Full time
Department/Location: Department of Cellular and Molecular Medicine
|